Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 6Sarcoma, Alveolar Soft Part 1Colorectal Neoplasms 1Chondrosarcoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

trifluridine tipiracil drug combination 1spartalizumab 1perifosine 1futibatinib 1anlotinib 1Tablets 1TAS-116 1Rosuvastatin Calcium 1Ramucirumab 1Midazolam 1Loperamide 1Gemcitabine 1Fluorouracil 1Digoxin 1Dacarbazine 1Cisplatin 1Carboplatin 1Bevacizumab 1Antiemetics 1Allopurinol 1ARQ 197 14-(2-fluoro-4-((((2-phenylacetyl)amino)thioxomethyl)amino)phenoxy)-7-methoxy-N-methyl-6-quinolinecarboxamide 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Sarcoma, Alveolar Soft Part × Loperamide × Clear all
NCT00401388 2018-03-07

A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas

AEterna Zentaris

Phase 2 Completed
72 enrolled
Sarcoma

Chondrosarcoma, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon âš¡